Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology Programs

NEXT STORY
Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
PREV STORY
EU Healthcare Market Predictions & Outlook, 2020 – Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing; Key Drivers of Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens

The collaboration with AbCheck will allow MolMed to enlarge its proprietary CAR pipeline for ...

author_avatar
NASDAQ Market News

Lateral Flow Diagnostic Tests Market in Asia Pacific is Estimated to Reach US$3.6 bn by 2023 at a CAGR of 5.7% from 2015 to 2023: Transparency Market Research

Albany, NY, Feb. 03, 2016 (GLOBE NEWSWIRE) -- According to a new market report ...

author_avatar
NASDAQ Market News

Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a biopharmaceutical ...

author_avatar
NASDAQ Market News